Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    Open Studies | "Poliomyelitis"
Show Display Options
Rank Status Study
1 Recruiting Safety and Immunogenicity of IPOVAC in Young Children
Condition: Poliomyelitis
Interventions: Biological: IMOVAC-POLIO;   Biological: IPOVAC 1.5:5:5;   Biological: IPOVAC, 3:10:10;   Biological: IPOVAC, 6:20:20
2 Not yet recruiting A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania
Condition: Poliomyelitis
Intervention: Biological: Sabin mOPV2
3 Not yet recruiting A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age
Condition: Poliomyelitis
Intervention: Biological: Oral Polio Vaccine
4 Recruiting L-Citrulline in Patients With Post-Polio Syndrome
Condition: Post-Polio Syndrome
Interventions: Drug: 15g L-citrulline daily p.o.;   Drug: Placebo
5 Recruiting A Clinical Study Comparing Safety and Immunogenicity of Bivalent Oral Polio Vaccine (bOPV) of Bilthoven Biologicals (BBio) With a Licensed bOPV
Condition: Immune Response to Oral Polio Vaccine
Interventions: Biological: Part 1 study - BBio bOPV;   Biological: Part 2 study - BBio bOPV Lot 1;   Biological: Part 2 study - BBio bOPV Lot 2;   Biological: Part 2 study - BBio bOPV Lot 3;   Biological: Part 2 study - Licensed bOPV;   Biological: Part 1 study - Licensed bOPV
6 Recruiting Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine
Condition: Poliomyelitis
Interventions: Biological: Single-dose regimen of high dosage investigational sIPV;   Biological: Single-dose regimen of medium dosage investigational sIPV;   Biological: Three-dose regimen of high dosage investigational sIPV;   Biological: Three-dose regimen of medium dosage investigational sIPV;   Biological: Three-dose regimen of low dosage investigational sIPV;   Biological: Three-dose regimen of commercialized sIPV;   Biological: Three-dose regimen of commercialized IPV
7 Recruiting Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Condition: Post-polio Syndrome
Interventions: Biological: Flebogamma 5% DIF;   Other: Placebo
8 Not yet recruiting A Campaign-based ID fIPV Administration Trial
Condition: Poliomyelitis
Interventions: Device: ID adaptor;   Device: ID Jet Injector (Tropis, Pharmajet);   Device: Needle and syringe
9 Recruiting Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study
Condition: Poliomyelitis
Interventions: Biological: IPV at 14 and 22 weeks of age, Rotarix;   Biological: IPV at 14 and 22 weeks of age, RotaTeq;   Biological: IPV at 14 and fIPV at 22 weeks, Rotarix;   Biological: IPV at 14 and fIPV at 22 weeks, RotaTeq;   Biological: IPV at 6 and fIPV at 22 weeks, Rotarix;   Biological: IPV at 6 and fIPV at 22 weeks, RotaTeq;   Biological: fIPV at 6-14-22 weeks of age, Rotarix;   Biological: fIPV at 6-14-22 weeks of age, RotaTeq
10 Recruiting Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Acellular Pertussis;   Tetanus;   Poliomyelitis;   Diphtheria
Interventions: Biological: Infanrix hexa;   Drug: Prevnar13
11 Not yet recruiting A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children
Condition: Adverse Event Following Immunisation
Intervention: Biological: SABIN monovalent OPV2
12 Recruiting Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Conditions: Spinal Cord Injuries;   Poliomyelitis;   Post-polio Syndrome;   Arthritis;   Lower Motor Neurone Lesion
Interventions: Device: C-brace;   Device: Stance control orthosis
13 Recruiting Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: DTaP-IPV combination vaccine;   Biological: DTaP vaccine and IPV vaccine
14 Recruiting Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
Conditions: Muscle Injury;   Nerve Injury;   Poliomyelitis;   Leprosy;   Cerebral Palsy
Interventions: Procedure: Interosseous route of TPTT;   Procedure: Extra membranous route of TPTT
15 Not yet recruiting Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Diphtheria;   Hepatitis B;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Tetanus;   Poliomyelitis
Intervention: Biological: Infanrix hexa
16 Recruiting Enhance Wellness for Individuals With Long-Term Physical Disabilities
Conditions: Multiple Sclerosis;   Muscular Dystrophy;   Post-polio Syndrome;   Spinal Cord Injury
Intervention: Behavioral: Enhance Wellness
17 Recruiting PVSRIPO for Recurrent Glioblastoma (GBM)
Conditions: GBM;   Glioblastoma;   Glioma;   Malignant Glioma
Intervention: Biological: PVSRIPO
18 Not yet recruiting PVSRIPO With/Without Lomustine
Condition: Malignant Glioma
Interventions: Biological: PVSRIPO;   Drug: Lomustine
19 Recruiting Clinical Trial of a Serious Game for Individuals With SCI/D
Conditions: Spinal Cord Injury;   Spinal Cord Involvement;   Spina Bifida;   Transverse Myelitis;   Polio and Post-polio Syndrome;   Syringomyelia;   Spinal Stenosis;   Spinal Neoplasms;   Spinal Cord Diseases
Intervention: Behavioral: SCI Hard
20 Recruiting DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Polio;   Human Immunodeficiency Virus Infection
Intervention: Biological: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine

Study has passed its completion date and status has not been verified in more than two years.